Biotech & Pharmaceutical Patenting
The patent landscape is changing, wherever in the world you are. In Europe there are moves towards creating a unified patent court, in China the 3rd amendment has just taken effect and in the US the impact of the new Obama administration on the patent landscape is still unknown.
In the pharmaceutical and biotech industries where protecting your pipeline is paramount, it is imperative that you are up to date with how these and other developments are going to impact your ability to protect and exploit your patents.
It is a truly international panel of speakers who will be sharing their experience and expertise with you at the 18th annual Biotech & Pharmaceutical Patenting conference in Munich.
